Skip to main content
SpringerLink
Log in
Book cover

Essentials of Interventional Techniques in Managing Chronic Pain pp 27–34Cite as

Pharmacology and Clinical Relevance of Commonly Used Drugs

  • Chapter
  • First Online:

  • 3252 Accesses

Abstract

Interventional pain medicine uses many different medications, including local anesthetics, corticosteroids, neurolytic agents, and radiocontrast media. The interventionalist must make an informed choice among the multiple alternatives in each class of medication. For some medications, the mechanisms of action are still not completely understood, and patient responses may vary due to genetic, epigenetic, and other factors in unexpected ways. Most medication decisions are based on a combination of theoretical knowledge and empirical evidence.

This is a preview of subscription content, log in via an institution.

References

  1. Calatayud J, González A. History of the development and evolution of local anesthesia since the coca leaf. Anesthesiology. 2003;98:1503–8.

    Article  PubMed  Google Scholar 

  2. Butterworth JF, Strichartz GR. Molecular mechanisms of local anesthesia: a review. Anesthesiology. 1990;72:711–34.

    Article  CAS  PubMed  Google Scholar 

  3. Becker DE, Reed KL. Essentials of local anesthetic pharmacology. Anesth Prog. 2006;53:98–109.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Tetzlaff JE, Tetzlaff SJ, Tetzlaff GA. Clinical pharmacology of local anesthetics. Boston: Butterworth-Heinemann; 2000.

    Google Scholar 

  5. Palkama VJ, Neuvonen PJ, Olkkola KT. Effect of itraconazole on the pharmacokinetics of bupivacaine enantiomers in healthy volunteers. Br J Anaesth. 1999;83:659–61.

    Article  CAS  PubMed  Google Scholar 

  6. Boren E, Teuber SS, Naguwa SM, et al. A critical review of local anesthetic sensitivity. Clin Rev Allergy Immunol. 2007;32:119–27.

    Article  CAS  PubMed  Google Scholar 

  7. Zink W, Graf BM. Local anesthetic myotoxicity. Reg Anesth Pain Med. 2004;29:333–40.

    Article  CAS  PubMed  Google Scholar 

  8. Reisner LS, Hochman BN, Plumer MH. Persistent neurologic deficit and adhesive arachnoiditis following intrathecal 2-chloroprocaine injection. Anesth Analg. 1980;59:452-454.

    Article  Google Scholar 

  9. Pollock JE. Transient neurologic symptoms: etiology, risk factors, and management. Reg Anesth Pain Med. 2002;27:581–6.

    PubMed  Google Scholar 

  10. Lund PC, Cwik JC. Propitocaine (Citanest) and methemoglobinemia. Anesthesiology. 1965;26:569–71.

    Article  CAS  PubMed  Google Scholar 

  11. Tsen LC, Tarshis J, Denson DD, et al. Measurements of maternal protein binding of bupivacaine throughout pregnancy. Anesth Analg. 1999;89:965–7.

    CAS  PubMed  Google Scholar 

  12. Neal JM, Mulroy MF, Weinberg GL. American Society of Regional Anesthesia and Pain Medicine checklist for managing local anesthetic systemic toxicity: 2012 version. Reg Anesth Pain Med. 2012;37:16–8.

    Article  PubMed  Google Scholar 

  13. Hench PS, Kendall EC, Slocumb C, et al. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clin. 1949;24:181–97.

    CAS  PubMed  Google Scholar 

  14. Schatzberg AF, Lindley S. Glucocorticoid antagonists in neuropsychotic disorders. Eur J Pharmacol. 2008;583:358–64.

    Article  CAS  PubMed  Google Scholar 

  15. Parente L. The development of synthetic glucocorticoids. In: Goulding NJ, Flower RJ, editors. Glucocorticoids. Basel: Birkhäuser Verlag; 2001. p. 35–51.

    Chapter  Google Scholar 

  16. Stewart AG. Mediators and receptors in the resolution of inflammation: drug targeting opportunities. Br J Pharmacol. 2009;158:933–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Newton R. Molecular mechanisms of glucocorticoid action: what is important? Thorax. 2000;55:603–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Mao J. Central glucocorticoid receptor: a new role in the cellular mechanisms of neuropathic pain. Rev Neurosci. 2005;16:233–8.

    Article  CAS  PubMed  Google Scholar 

  19. Stahn C, Buttgereit F. Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol. 2008;4:525–33.

    Article  CAS  PubMed  Google Scholar 

  20. Groeneweg FL, Karst H, de Kloet ER, et al. Rapid non-genomic effects of corticosteroids and their role in the central stress response. J Endocrinol. 2011;209:153–67.

    Article  CAS  PubMed  Google Scholar 

  21. Ding Y, Gao ZG, Jacobson KA, et al. Dexamethasone enhances ATP-induced inflammatory responses in endothelial cells. J Pharmacol Exp Ther. 2010;335:693–702.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Rosenbaum AH, Schatzberg AF, MacLaughlin RA, et al. The dexamethasone suppression test in normal control subjects: comparison of two assays and effect of age. Am J Psychiatry. 1984;141:1550–5.

    Article  CAS  PubMed  Google Scholar 

  23. Potvin O, Forget H, Préville M, et al. Relationship between cortisol level and prevalent/incident cognitive impairment and its moderating factors in older adults. Int Psychogeriatr. 2013;25:252–62.

    Article  PubMed  Google Scholar 

  24. Von Korff M, Crane P, Lane M, et al. Chronic spinal pain and physical–mental comorbidity in the United States: results from the national comorbidity survey replication. Pain. 2005;113:331–9.

    Article  Google Scholar 

  25. Derby R, Lee SH, Lee JH, et al. Size and aggregation of corticosteroids used for epidural injections. Pain Med. 2008;9:227–34.

    Article  PubMed  Google Scholar 

  26. Kennedy DJ, Plastaras C, Casey E, et al. Comparative effectiveness of lumbar transforaminal epidural steroid injections with particulate versus nonparticulate corticosteroids for lumbar radicular pain due to intervertebral disc herniation: a prospective, randomized, double-blind trial. Pain Med. 2014;15:548–55.

    Article  PubMed  Google Scholar 

  27. Noe CE, Haynsworth RF Jr. Comparison of epidural Depo-Medrol vs. aqueous betamethasone in patients with low back pain. Pain Pract. 2003;3:222–5.

    Article  PubMed  Google Scholar 

  28. Braun T, Challis JR, Newnham JP, et al. Early-life glucocorticoid exposure: the hypothalamic-pituitary-adrenal axis, placental function, and long-term disease risk. Endocr Rev. 2013;34:885–916.

    Article  CAS  PubMed  Google Scholar 

  29. Casadevall A, Pirofski LA. Exserohilum rostratum fungal meningitis associated with methylprednisolone injections. Future Microbiol. 2013;8:135–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Benzon HT. Compounded steroids for epidural injections: what are the issues? Anesth Analg. 2013;117:523–6.

    Article  PubMed  Google Scholar 

  31. Boyce JM, Lee L, Topal J, et al. Response to mold contamination of intravenous magnesium sulfate produced by a compounding pharmacy. JAMA Intern Med. 2014;174:630–1.

    Article  PubMed  Google Scholar 

  32. Guharoy R, Noviasky J, Haydar Z, et al. Compounding pharmacy conundrum: “we cannot live without them but we cannot live with them” according to the present paradigm. Chest. 2013;143:896–900.

    Article  PubMed  Google Scholar 

  33. Aqeel I, Garcha AS, Rudnick MR. Relative nephrotoxicity of different contrast media. Intervent Cardiol Clin. 2014;3:349–56.

    Article  PubMed  Google Scholar 

  34. Sendeski MM. Pathophysiology of renal tissue damage by iodinated contrast media. Clin Exp Pharmacol Physiol. 2011;38:292–9.

    Article  CAS  PubMed  Google Scholar 

  35. Morcos SK. Acute serious and fatal reactions to contrast media: our current understanding. Br J Radiol. 2005;78:686–93.

    Article  CAS  PubMed  Google Scholar 

  36. Morcos SK, Thomsen HS, Webb JA, Contrast Media Safety Committee of the European Society of Urogenital Radiology. Prevention of generalized reactions to contrast media: a consensus report and guidelines. Eur Radiol. 2001;11:1720–8.

    Article  CAS  PubMed  Google Scholar 

  37. Sindou M, Georgoulis G, Mertens P. History of neurosurgical treatment for spasticity. In: Neurosurgery for spasticity: a practice guide for treating children and adults. Vienna: Springer; 2014. p. 7–17.

    Chapter  Google Scholar 

  38. Abdalla EK, Schell SR. Paraplegia following intraoperative celiac plexus injection. J Gastrointest Surg. 1999;3:668–71.

    Article  CAS  PubMed  Google Scholar 

  39. Galizia EJ, Lahiri SK. Paraplegia following coeliac plexus block with phenol. Case report. Br J Anaesth. 1974;46:539–40.

    Article  CAS  PubMed  Google Scholar 

  40. Lawson EF, Wallace MS. Neurolytic agents. In: Comprehensive treatment of chronic pain by medical, interventional, and integrative approaches. New York: Springer; 2013. p. 263–76.

    Chapter  Google Scholar 

  41. Labat G, Greene M. Contribution to the modern method of diagnosis and treatment of the so-called sciatic neuralgias: case reports. Am J Surg. 1931;11:435–51.

    Article  Google Scholar 

  42. Thompson GE, Moore DC, Bridenbaugh LD, et al. Abdominal pain and alcohol celiac plexus nerve block. Anesth Analg. 1977;56:1–5.

    Article  CAS  PubMed  Google Scholar 

  43. Noda J, Umeda S, Mori K, et al. Disulfiram-like reaction associated with carmofur after celiac plexus alcohol block. Anesthesiology. 1987;67:809–10.

    Article  CAS  PubMed  Google Scholar 

  44. Wilkinson IM, Cohen SP, Erdek MA. Complications associated with neurolytic celiac plexus block. In: Neal JM, Rathmell JP, editors. Complications in regional anesthesia and pain medicine. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 257–64.

    Google Scholar 

  45. Maher R. Relief of pain in incurable cancer. Lancet. 1955;265:18–20.

    Article  Google Scholar 

  46. Benzon HT. Convulsions secondary to intravascular phenol: a hazard of celiac plexus block. Anesth Analg. 1979;58:150-151.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of Washington, Seattle, WA, USA

    Natalia Murinova

  2. Departments of Psychiatry, Anesthesia, and Pain Medicine, Harborview Medical Center, Seattle, WA, USA

    Daniel Krashin

  3. Department of Anesthesia, LSU Health Science Center, New Orleans, LA, USA

    Alan D. Kaye

Authors
  1. Natalia Murinova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel Krashin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alan D. Kaye
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Natalia Murinova .

Editor information

Editors and Affiliations

  1. Pain Management Center of Paducah, Paducah, Kentucky

    Laxmaiah Manchikanti

  2. Department of Anesthesia, LSU Health Science Center, New Orleans, Louisiana, USA

    Alan D. Kaye

  3. Mid Atlantic Spine and Pain Physicians, Newark, Delaware

    Frank J.E. Falco

  4. Service Line Chief of Interventional Radiology, Director of Interventional Neuroradiology, Chief of NeuroInterventional Spine Service, Massachusetts General Hospital, Boston, Massachusetts, USA

    Joshua A. Hirsch

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Murinova, N., Krashin, D., Kaye, A.D. (2018). Pharmacology and Clinical Relevance of Commonly Used Drugs. In: Manchikanti, L., Kaye, A., Falco, F., Hirsch, J. (eds) Essentials of Interventional Techniques in Managing Chronic Pain. Springer, Cham. https://doi.org/10.1007/978-3-319-60361-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-60361-2_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-60359-9

  • Online ISBN: 978-3-319-60361-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation